Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-NGFR antibody (121-170) (STJ94481) | Login | Anti-NGFR antibody (121-170) (STJ94481) | ||||||||||||||||
|
||||||||||||||||||
Anti-NBN antibody (251-300) (STJ94486) | Login | Anti-NBN antibody (251-300) (STJ94486) | ||||||||||||||||
|
||||||||||||||||||
Anti-TACR2 antibody (301-350) (STJ94497) | Login | Anti-TACR2 antibody (301-350) (STJ94497) | ||||||||||||||||
|
||||||||||||||||||
Anti-NFE2L2 antibody (556-605) (STJ94554) | Login | Anti-NFE2L2 antibody (556-605) (STJ94554) | ||||||||||||||||
|
||||||||||||||||||
Anti-NPM1 antibody (1-50) (STJ94573) | Login | Anti-NPM1 antibody (1-50) (STJ94573) | ||||||||||||||||
|
||||||||||||||||||
Anti-NUMA1 antibody (334-383) (STJ94575) | Login | Anti-NUMA1 antibody (334-383) (STJ94575) | ||||||||||||||||
|
||||||||||||||||||
Anti-NR4A1 antibody (317-366) (STJ94578) | Login | Anti-NR4A1 antibody (317-366) (STJ94578) | ||||||||||||||||
|
||||||||||||||||||
Anti-SLCO1A2 antibody (251-300) (STJ94586) | Login | Anti-SLCO1A2 antibody (251-300) (STJ94586) | ||||||||||||||||
|
||||||||||||||||||
Anti-CDH11 antibody (421-470) (STJ94589) | Login | Anti-CDH11 antibody (421-470) (STJ94589) | ||||||||||||||||
|
||||||||||||||||||
Anti-DDX3X antibody (466-515 aa) (STJ92676) | Login | Anti-DDX3X antibody (466-515 aa) (STJ92676) | ||||||||||||||||
|
||||||||||||||||||
Anti-DDX3 antibody (14-63 aa) (STJ92677) | Login | Anti-DDX3 antibody (14-63 aa) (STJ92677) | ||||||||||||||||
|
||||||||||||||||||
Anti-DDX3Y antibody (41-90 aa) (STJ92678) | Login | Anti-DDX3Y antibody (41-90 aa) (STJ92678) | ||||||||||||||||
|
||||||||||||||||||
Anti-OR51E1 antibody (241-290 aa) (STJ92705) | Login | Anti-OR51E1 antibody (241-290 aa) (STJ92705) | ||||||||||||||||
|
||||||||||||||||||
Anti-DMPK antibody (11-60 aa) (STJ92728) | Login | Anti-DMPK antibody (11-60 aa) (STJ92728) | ||||||||||||||||
|
||||||||||||||||||
Anti-LIG3 antibody (110-190 aa) (STJ92730) | Login | Anti-LIG3 antibody (110-190 aa) (STJ92730) | ||||||||||||||||
|
||||||||||||||||||
Anti-LIG4 antibody (616-665 aa) (STJ92731) | Login | Anti-LIG4 antibody (616-665 aa) (STJ92731) | ||||||||||||||||
|
||||||||||||||||||
Anti-LIG4 antibody (591-640 aa) (STJ92732) | Login | Anti-LIG4 antibody (591-640 aa) (STJ92732) | ||||||||||||||||
|
||||||||||||||||||
Anti-POLB antibody (286-335 aa) (STJ92734) | Login | Anti-POLB antibody (286-335 aa) (STJ92734) | ||||||||||||||||
|
||||||||||||||||||
Anti-PRKDC antibody (4061-4110 aa) (STJ92750) | Login | Anti-PRKDC antibody (4061-4110 aa) (STJ92750) | ||||||||||||||||
|
||||||||||||||||||
Anti-DZIP3 antibody (681-730 aa) (STJ92805) | Login | Anti-DZIP3 antibody (681-730 aa) (STJ92805) | ||||||||||||||||
|
||||||||||||||||||
Anti-SLC1A1 antibody (122-171 aa) (STJ92814) | Login | Anti-SLC1A1 antibody (122-171 aa) (STJ92814) | ||||||||||||||||
|
||||||||||||||||||
Anti-E-cadherin antibody (833-882 aa) (STJ92819) | Login | Anti-E-cadherin antibody (833-882 aa) (STJ92819) | ||||||||||||||||
|
||||||||||||||||||
Anti-IRAK1 antibody (353-402 aa) (STJ93756) | Login | Anti-IRAK1 antibody (353-402 aa) (STJ93756) | ||||||||||||||||
|
||||||||||||||||||
Anti-IRAK2 antibody (Internal) (STJ93757) | Login | Anti-IRAK2 antibody (Internal) (STJ93757) | ||||||||||||||||
|
||||||||||||||||||
Anti-IRAK3 antibody (491-540 aa) (STJ93758) | Login | Anti-IRAK3 antibody (491-540 aa) (STJ93758) | ||||||||||||||||
|